UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026802
Receipt number R000030767
Scientific Title Study of high serum IgG4 concentrations in liver cirrhosis
Date of disclosure of the study information 2017/04/01
Last modified on 2020/10/07 10:43:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of high serum IgG4 concentrations in liver cirrhosis

Acronym

High serum IgG4 concentrations in patients with liver cirrhosis

Scientific Title

Study of high serum IgG4 concentrations in liver cirrhosis

Scientific Title:Acronym

High serum IgG4 concentrations in patients with liver cirrhosis

Region

Japan


Condition

Condition

Liver cirrhosis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the relationship between liver cirrhosis and high serum IgG4 concentrations.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To clarify the relationship between liver cirrhosis and high serum IgG4 concentrations.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who will visit as outpatient or be admitted.
2. Patients diagnosed with liver cirrhosis.

Key exclusion criteria

None

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kazuhiko
Middle name
Last name Nakao

Organization

Nagasaki University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7481

Email

kazuhiko@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Yuri
Middle name
Last name Miyazoe

Organization

Nagasaki University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7481

Homepage URL


Email

yurieast10@hotmail.com


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital

Address

1-7-1 Sakamoto, Nagasaki

Tel

095-819-7905

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 31 Day

Date of IRB

2017 Year 04 Month 07 Day

Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2019 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not paticular


Management information

Registered date

2017 Year 03 Month 31 Day

Last modified on

2020 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030767


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name